David E. Misek

16.8k total citations · 2 hit papers
95 papers, 11.1k citations indexed

About

David E. Misek is a scholar working on Molecular Biology, Spectroscopy and Oncology. According to data from OpenAlex, David E. Misek has authored 95 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Molecular Biology, 22 papers in Spectroscopy and 16 papers in Oncology. Recurrent topics in David E. Misek's work include Advanced Proteomics Techniques and Applications (21 papers), Glycosylation and Glycoproteins Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). David E. Misek is often cited by papers focused on Advanced Proteomics Techniques and Applications (21 papers), Glycosylation and Glycoproteins Research (17 papers) and Monoclonal and Polyclonal Antibodies Research (16 papers). David E. Misek collaborates with scholars based in United States, Australia and France. David E. Misek's co-authors include Samir Hanash, Thomas J. Giordano, Rork Kuick, Jeremy M. G. Taylor, David G. Beer, Mark B. Orringer, Guoan Chen, Tarek G. Gharib, Sharon L. R. Kardia and Dafydd G. Thomas and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David E. Misek

94 papers receiving 10.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gene-expression profiles predict survival of patients with lung adenocarcinoma

2002 1.5k citations David G. Beer, Sharon L. R. Kardia et al. profile →
Discordant Protein and mRNA Expression in Lung Adenocarcinomas

2002 790 citations Guoan Chen, Tarek G. Gharib et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Misek United States	53	7.1k	2.0k	2.0k	1.6k	1.4k	95	11.1k
Fredrik Pontén Sweden	60	8.3k 1.2×	3.7k 1.9×	2.8k 1.4×	1.8k 1.2×	1.1k 0.8×	272	14.2k
Michael R. Emmert‐Buck United States	55	6.9k 1.0×	2.1k 1.1×	2.6k 1.3×	505 0.3×	1.3k 1.0×	177	10.8k
Rork Kuick United States	56	7.8k 1.1×	2.4k 1.2×	3.4k 1.7×	1.5k 1.0×	639 0.5×	156	13.0k
Karl R. Clauser United States	49	7.2k 1.0×	2.2k 1.1×	1.1k 0.6×	1.5k 0.9×	3.0k 2.2×	84	11.6k
Emanuel F. Petricoin United States	51	6.7k 0.9×	1.5k 0.8×	1.2k 0.6×	878 0.6×	2.3k 1.7×	195	9.5k
Samuel C. Mok United States	67	7.7k 1.1×	3.5k 1.8×	3.7k 1.9×	1.8k 1.2×	501 0.4×	243	14.2k
Anthony D. Whetton United Kingdom	52	5.2k 0.7×	1.4k 0.7×	1.0k 0.5×	1.2k 0.8×	1.0k 0.7×	277	8.9k
Alexander D. Borowsky United States	51	4.7k 0.7×	2.6k 1.3×	1.6k 0.8×	1.1k 0.7×	334 0.2×	197	8.7k
Yiling Lu United States	64	11.6k 1.6×	3.5k 1.8×	2.9k 1.5×	1.4k 0.9×	373 0.3×	209	15.6k
Roger J. Daly Australia	59	10.5k 1.5×	3.4k 1.7×	1.7k 0.9×	1.4k 0.9×	272 0.2×	173	14.0k

Countries citing papers authored by David E. Misek

Since Specialization

Citations

This map shows the geographic impact of David E. Misek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Misek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Misek more than expected).

Fields of papers citing papers by David E. Misek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Misek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Misek. The network helps show where David E. Misek may publish in the future.

Co-authorship network of co-authors of David E. Misek

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Misek. A scholar is included among the top collaborators of David E. Misek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Misek. David E. Misek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Misek, David E., Tadashi Kondo, & Mark W. Duncan. (2011). Proteomics-Based Disease Biomarkers. PubMed. 2011. 1–2.

Vilar, Eduardo, Bhramar Mukherjee, Rork Kuick, et al.. (2009). Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin Pathway. Clinical Cancer Research. 15(8). 2829–2839. 46 indexed citations

Paczesny, Sophie, Oleg I. Krijanovski, Thomas Braun, et al.. (2008). A biomarker panel for acute graft-versus-host disease. Blood. 113(2). 273–278. 290 indexed citations

Kuick, Rork, Eric Puravs, Qing Zhang, et al.. (2007). Identification of 14-3-3𝛉 as an Antigen that Induces a Humoral Response in Lung Cancer. Cancer Research. 67(24). 12000–12006. 67 indexed citations

Chen, Jianzhong, Michelle A. Anderson, David E. Misek, Diane M. Simeone, & David M. Lubman. (2007). Characterization of apolipoprotein and apolipoprotein precursors in pancreatic cancer serum samples via two-dimensional liquid chromatography and mass spectrometry. Journal of Chromatography A. 1162(2). 117–125. 37 indexed citations

Kuick, Rork, David E. Misek, David J. Monsma, et al.. (2007). Discovery of cancer biomarkers through the use of mouse models. Cancer Letters. 249(1). 40–48. 26 indexed citations

Misek, David E., Rork Kuick, Hong Wang, et al.. (2005). A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. PROTEOMICS. 5(13). 3343–3352. 58 indexed citations

Giordano, Thomas J., Rork Kuick, Dafydd G. Thomas, et al.. (2005). Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis. Oncogene. 24(44). 6646–6656. 291 indexed citations

Kuick, Rork, Randal Orchekowski, David E. Misek, et al.. (2005). Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis. BMC Cancer. 5(1). 110–110. 131 indexed citations

10.

Misek, David E., et al.. (2004). Hepatitis C virus NS5A-regulated gene expression and signaling revealed via microarray and comparative promoter analyses. Hepatology. 40(3). 708–718. 30 indexed citations

11.

Misek, David E., Rork Kuick, Samir Hanash, & Craig D. Logsdon. (2004). Oligonucleotide-Directed Microarray Gene Profiling of Pancreatic Adenocarcinoma. Humana Press eBooks. 103. 175–188. 1 indexed citations

12.

Miller, Charles T., Guoan Chen, Tarek G. Gharib, et al.. (2003). Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas. Oncogene. 22(39). 7950–7957. 76 indexed citations

13.

Misek, David E., et al.. (2003). Inducible Expression of Macrophage Receptor Marco by Dendritic Cells Following Phagocytic Uptake of Dead Cells Uncovered by Oligonucleotide Arrays. The Journal of Immunology. 171(6). 2879–2888. 42 indexed citations

14.

Nam, Myeong Jin, Juan Madoz‐Gúrpide, Hong Wang, et al.. (2003). Molecular profiling of the immune response in colon cancer using protein microarrays: Occurrence of autoantibodies to ubiquitin C‐terminal hydrolase L3. PROTEOMICS. 3(11). 2108–2115. 93 indexed citations

15.

Ji, Baoan, et al.. (2003). Pancreatic gene expression during the initiation of acute pancreatitis: identification of EGR-1 as a key regulator. Physiological Genomics. 14(1). 59–72. 89 indexed citations

16.

Logsdon, Craig D., Diane M. Simeone, Charles E. Binkley, et al.. (2003). Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer.. PubMed. 63(10). 2649–57. 452 indexed citations

17.

Schwartz, Donald R., Sharon L. R. Kardia, Kerby Shedden, et al.. (2002). Gene expression in ovarian cancer reflects both morphology and biological behavior, distinguishing clear cell from other poor-prognosis ovarian carcinomas.. PubMed. 62(16). 4722–9. 348 indexed citations

18.

Misek, David E., Christina L. ␣Chang, Rork Kuick, et al.. (2002). Transforming properties of a Q18→E mutation of the microtubule regulator Op18. Cancer Cell. 2(3). 217–228. 23 indexed citations

19.

Vassilatis, Demetrios K., Dickson D. Despommier, David E. Misek, et al.. (1992). Analysis of a 43-kDa glycoprotein from the intracellular parasitic nematode Trichinella spiralis.. Journal of Biological Chemistry. 267(26). 18459–18465. 71 indexed citations

20.

Rodríguez-Boulan, Enrique, et al.. (1985). Chapter 6 Protein Sorting in the Secretory Pathway. PubMed. 24. 251–294. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact